TSE:SVA Stock Latest News
Company AnnouncementsSeraxis and Sernova Tap Former FDA Leader as CMO Ahead of BetaNova Merger1w ago
Company AnnouncementsSernova and Seraxis Secure US$11.2 Million to Fund BetaNova Merger and Advance T1D Cell Therapy2w ago
Pre-EarningsSVA Earnings this Week: How Will it Perform?1M ago
Pre-EarningsSernova Corp (SVA) Q2 Earnings Cheat Sheet4M agoCompany AnnouncementsSernova Shareholders Approve Debt-Reducing Issuances and Re-elect Board at 2026 AGM6M ago
Company AnnouncementsSernova Raises $2.1 Million in Private Placement to Advance Diabetes Program7M ago
Company AnnouncementsSernova Bolsters Balance Sheet With $7.1 Million Financing and Debt Retirement Plan8M ago
Company AnnouncementsSernova Amends Warrants to Extend Terms and Cut Exercise Prices for Investors8M ago
Company AnnouncementsSernova Biotherapeutics Advances Diabetes Treatment with New Funding11M ago
Company AnnouncementsSernova Biotherapeutics Strengthens Financial Position with Debt-to-Equity Conversion1y ago
Company AnnouncementsSernova Biotherapeutics Appoints John L. Brooks III as Board Chair to Advance Diabetes Cure1y ago
Company AnnouncementsSernova Biotherapeutics Appoints Interim Chair Amid Strategic Advancements1y ago
Company AnnouncementsSernova Biotherapeutics Forms Clinical Advisory Board to Advance Diabetes Treatment1y ago
Company AnnouncementsSernova’s Cell Pouch Shows Promising Results in Diabetes Trial1y agoCompany AnnouncementsSernova Biotherapeutics Secures $4 Million Loan for Clinical Advancements1y ago




